Global Credit Crisis Said To Open Doors For Malaysian Biotechs
This article was originally published in PharmAsia News
Executive Summary
The current worldwide economic crisis puts Malaysian startup biotechnology companies in a good position to seek mergers and acquisitions to expand their business abroad. CEO Datuk Iskandar Mizal Mahmood of Malaysian Biotechnology said Malaysia's organization of biotechs, BioNexus, can help raise funds to buy foreign biotechs. They would be firms facing problems with obtaining credit, particularly those in the United States and Europe. He said many of those foreign companies already are seeking collaborations. (Click here for more